A Double-Blind, Randomised, Placebo-Controlled Study to Assess the Safety of Cat-PAD in Cat Allergic Subjects With Controlled Asthma

Trial Profile

A Double-Blind, Randomised, Placebo-Controlled Study to Assess the Safety of Cat-PAD in Cat Allergic Subjects With Controlled Asthma

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Apr 2015

At a glance

  • Drugs Cat SPIRE (Primary)
  • Indications Asthma; Rhinoconjunctivitis
  • Focus Adverse reactions
  • Sponsors Circassia
  • Most Recent Events

    • 26 Feb 2013 Results presented at the 69th Annual Meeting of the American Academy of Allergy, Asthma and Immunology.
    • 11 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 09 Dec 2009 Planned end date changed from 1 Oct 2009 to 1 Apr 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top